The Japanese Journal of Nephrology
Online ISSN : 1884-0728
Print ISSN : 0385-2385
ISSN-L : 0385-2385
High-dose intravenous gammaglobulin for membranous nephropathy (MN), membranoproliferative glomerulonephritis (MPGN) and lupus nephritis (LN)
TETSUZO SUGISAKISHGEYO SHIWACHISHOGO ITOMASAHIRO YONEKURAKOZO KITAZAWAJUN YAMAMOTOJUN UCHIDAHISASHI KAWASUMIKENICHII SATOTAKANORI SHIBATASHIGERU TAKASEKEIKO SOEDA
Author information
JOURNALS FREE ACCESS

1983 Volume 25 Issue 6 Pages 697-708

Details
Abstract

Three cases of idiopathic MN, 2 of MPGN and 3 of LN were demonstrated IgG de-posits along glomerular capillary walls in granular pattern and were dissociated after incubation with human γ-globulin. Furthermore, the dissociation of IgG in glomeruli was observed following incubation with plasmin-treated, PEG-treated, sulfonated kuman γ-globulin and Fc fragment, but not with pepsin-treated human γ-globulin, indicating that Fc fragment may play an important role for the dissociation. These results suggest that immune complexes in the glomeruli consist of the patient's own denatured IgG and IgG-RF. On the basis of these findings, all of the patients were treated with large intravenous dose of plasmin-treated γ-globulin (5g/day, 610 times). In all patients the urine protein and/or hematuria rematuria remarkedly decreased or disappeared within 7 days to 40 days. During 60 to 90 days of observation all patients with these renal diseases could be main-tained in improved status from nephrotic syndrome. No untoward effects of γ-globulin therapy were observed. Thus, administration of high-dose intravenous γ-globulin is useful treatment for MN, LN and MPGN.

Information related to the author
© Japanese Society of Nephrology
Previous article Next article
feedback
Top